<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01226225</url>
  </required_header>
  <id_info>
    <org_study_id>IWT-090870</org_study_id>
    <nct_id>NCT01226225</nct_id>
  </id_info>
  <brief_title>A Multicentre Trial on the Effectiveness of Physical Rehabilitation of Patients With Coronary Artery Disease: Aerobic Interval Training Versus Moderate Continuous Training.</brief_title>
  <acronym>SAINTEX-CAD</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac rehabilitation, including physical training, has become accepted treatment following&#xD;
      myocardial infarction, coronary stent implantation and coronary bypass operation. Besides&#xD;
      modifying patients' risk profile for future coronary problems, the focus is on improving&#xD;
      exercise capacity. The ability to be able to perform at a higher maximal level is a strong&#xD;
      predictor for outcome (new cardiovascular events and mortality). The main purpose of this&#xD;
      study is to evaluate whether aerobic interval training outweighs more classical moderate&#xD;
      endurance training in improving exercise capacity. During interval training, patients perform&#xD;
      exercise at high intensity, but for only a couple of minutes and then recover at a lower&#xD;
      intensity. Such intervals are repeated. Preliminary evidence from smaller studies suggests&#xD;
      that this type of training leads to a larger increase in exercise capacity, compared to the&#xD;
      more traditional endurance training at moderate intensity.&#xD;
&#xD;
      In addition, mechanisms that might explain how this improvement is achieved, as well as&#xD;
      safety and impact on quality of life will be studied.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal aerobic capacity, measured during symptom-limited cardio-pulmonary exercise testing</measure>
    <time_frame>6 weeks</time_frame>
    <description>Comparison of evolution of maximal aerobic capacity from baseline to 6 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal aerobic capacity, measured during symptom-limited cardio-pulmonary exercise testing</measure>
    <time_frame>12 weeks</time_frame>
    <description>Comparison of evolution of maximal aerobic capacity from baseline to 12 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal aerobic capacity, measured during symptom-limited cardio-pulmonary exercise testing</measure>
    <time_frame>12 months</time_frame>
    <description>Comparison of evolution of maximal aerobic capacity, measured during symptom-limited cardio-pulmonary exercise testing</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Artery Disease (CAD);</condition>
  <condition>Myocardial Infarction (MI)</condition>
  <condition>Percutaneous Coronary Intervention (PCI)</condition>
  <condition>Coronary Artery Bypass Grafting (CABG)</condition>
  <arm_group>
    <arm_group_label>Aerobic interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate endurance training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic interval training</intervention_name>
    <description>Patients will enter a training program during which aerobic interval training is implemented. Three sessions per week, each lasting for 60 minutes. Total duration of the program: 3 months.</description>
    <arm_group_label>Aerobic interval training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Moderate endurance training</intervention_name>
    <description>Patients will enter a training program during which moderate endurance training is implemented. Three sessions per week, each lasting for 60 minutes. Total duration of the program: 3 months.</description>
    <arm_group_label>Moderate endurance training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with CAD (post-PCI, post-MI, post-CABG) and a left ventricular ejection&#xD;
             fraction (LVEF) &gt; 40%&#xD;
&#xD;
          -  the presence of CAD is defined as prior angiographically documented stenotic lesion(s)&#xD;
             of &gt; 75%, or documented myocardial infarction (biochemical, ECG, echocardiographic&#xD;
             documentation).&#xD;
&#xD;
          -  patients are on optimal medical treatment and stable with regard to symptoms and&#xD;
             pharmacotherapy for at least 4 weeks&#xD;
&#xD;
          -  in practice, patients will have been hospitalized at least 4 weeks prior to&#xD;
             participation in the training programme because of PCI, MI or CABG&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant intercurrent illness last 6 weeks&#xD;
&#xD;
          -  known severe ventricular arrhythmia with functional or prognostic significance&#xD;
&#xD;
          -  significant myocardial ischemia, hemodynamic deterioration or exercise-induced&#xD;
             arrhythmia at baseline testing&#xD;
&#xD;
          -  recent CABG (&lt; 30 days)&#xD;
&#xD;
          -  other heart disease that limits exercise tolerance (valve disease with significant&#xD;
             hemodynamic consequences, hypertrophic cardiomyopathy etc.)&#xD;
&#xD;
          -  co-morbidity that may significantly influence one-year prognosis&#xD;
&#xD;
          -  functional or mental disability that may limit exercise&#xD;
&#xD;
          -  a habit of regular vigorous exercise or participation in a programme of exercise&#xD;
             training less than 3 months before inclusion&#xD;
&#xD;
          -  acute or chronic inflammatory diseases or malignancy, the use of anti-inflammatory&#xD;
             drugs or immune suppression&#xD;
&#xD;
          -  glomerular filtration rate (GFR) &lt;25ml/min/1.73m2&#xD;
&#xD;
          -  hemoglobin &lt; 10g/dl&#xD;
&#xD;
          -  severe chronic obstructive pulmonary disease&#xD;
&#xD;
          -  participation in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Viviane M Conraads, MD, PhD</last_name>
    <phone>38214672</phone>
    <phone_ext>0032</phone_ext>
    <email>Viviane.Conraads@uza.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viviane M Conraads, MD,PhD</last_name>
      <phone>38214672</phone>
      <phone_ext>0032</phone_ext>
      <email>Viviane.Conraad@uza.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Leuven, Dienst Hart- en Vaatziekten, Cardiale Revalidatie Herestraat 49</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luc VanHees, MSc, PhD</last_name>
      <phone>16-329158</phone>
      <phone_ext>0032</phone_ext>
      <email>Luc.Vanhees@faber.kuleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <study_first_submitted>August 19, 2010</study_first_submitted>
  <study_first_submitted_qc>October 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2010</study_first_posted>
  <last_update_submitted>November 9, 2010</last_update_submitted>
  <last_update_submitted_qc>November 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Antwerp University Hospital, Belgium</name_title>
    <organization>Antwerp University Hospital, Belgium</organization>
  </responsible_party>
  <keyword>Patients with recent coronary event</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

